BIVDA have released the following statement on DCB0129, which can be downloaded here and read below:
Ben KempSeptember 8, 2023
This is a final reminder that BIVDA’s Parliamentary Reception on the House of Commons Terrace is next week on Wednesday 13 September between 13:30 – 15:30. Please note that smart dress is required. Please ensure that you bring an electronic or printed copy of your invitation. If you do not have a copy of your invitation, please email bivdareception@hanovercomms.com. Parliament…
Ben KempSeptember 8, 2023
At the Point of Care: The Power to Disrupt, London 2023 conference held at the Royal College of Pathologists and hosted by Thornhill Healthcare Events (Tony Cambridge); BIVDA delivered a thought-provoking presentation on the opportunities and challenges in the UK facing POCT testing and its potential to deliver dramatic and positive changes in care pathways for patients and service delivery…
Ben KempAugust 25, 2023
Detail of outcome The results of this call for evidence will inform the development of the next 5-year national action plan (NAP) on antimicrobial resistance (AMR), which will run from 2024 to 2029. The 2024 to 2029 NAP will continue being developed in consultation with a broad range of stakeholders across different sectors. It will build on the achievements of the…
Ben KempAugust 25, 2023
This consultation asks for feedback on UK SMI V 44: laboratory diagnosis of syphilis. This consultation closes at midday on 5 September 2023 Consultation description UK Health Security Agency (UKHSA) has opened a consultation in joint partnership with professional organisations. This consultation asks for feedback in relation to the UK Standards for Microbiology Investigations (UK SMI) V 44: laboratory diagnosis…
Ben KempAugust 25, 2023
More investment needed to ensure ICS success, health leaders say A new report has found underinvestment is hampering the progress of ICSs. Staff pressures, financial constraints, issues in the social care sector – alongside the continued disruption from industrial action – were identified as the main barriers to success by ICS leaders. The health leaders polled were, however, supportive of…
Ben KempAugust 25, 2023
A novel blood test may revolutionise early diagnosis of some diseases among diabetics. The breakthrough test can detect four biomarkers which are indicative of future heart and kidney issues among people with diabetes. A study has also discovered that taking a drug called canagliflozin lowers the level of those four biomarkers compared to those who took a placebo. Doctors regularly…
Ben KempAugust 25, 2023
New trials launched by the NHS are aiming to understand how wireless technology can further benefit the health service, notably how efficiency of existing digital infrastructure and connectivity can be impacted. Funding can be sought via the Connectivity Hub for projects which seek to improve digital technology. Applications are to run from this summer and will then be reviewed across…
Ben KempAugust 25, 2023
Spatial Biology Europe 2023: 12 – 13 September 2023 | Amsterdam, Netherlands Spatial Biology Europe 2023 is a high-level environment purpose built for connecting with the spatial community, sharing knowledge, and exchanging insights on the latest innovations in spatial research and technologies. Count yourself amongst the industry’s brightest minds and join us this September to pave the way for the future…
Ben KempAugust 25, 2023
The 100 Days Mission was launched in 2021 under the UK’s G7 presidency to bring together like-minded nations to better prepare for the next pandemic by pre-emptively and proactively driving the development of diagnostics, therapeutics, and vaccines (DTVs) so that they can be rapidly deployed within the first 100 days of a future pandemic threat being identified. In this article,…
Ben KempAugust 25, 2023